Selected research
Industry Growth & Trends
Global Propofol Emulsion Injection Industry Growth and Trends Forecast to 2032
Market perspective
The global Propofol Emulsion Injection market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for Propofol Emulsion Injection is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for Propofol Emulsion Injection is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Propofol Emulsion Injection is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Propofol Emulsion Injection include Xian Libang Pharmaceutical, Teva, Sandoz, Jiangsu Nhwa Group, Pfizer, Sinopharm Guorui Pharm, Guangdong Jiabo Pharmaceutical, Fresenius Kabi and Baxter, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global Propofol Emulsion Injection market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The Propofol Emulsion Injection market size, estimates, and forecasts are presented in terms of sales volume (W Units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Propofol Emulsion Injection market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Propofol Emulsion Injection.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading manufacturers in the global Propofol Emulsion Injection market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
Propofol Emulsion Injection Market by Company
Xian Libang Pharmaceutical
Teva
Sandoz
Jiangsu Nhwa Group
Pfizer
Sinopharm Guorui Pharm
Guangdong Jiabo Pharmaceutical
Fresenius Kabi
Baxter
AstraZeneca
Sagent
Dr. Reddy's
B Braun
Propofol Emulsion Injection Segment by Type
20ml/vial
50ml/vial
100ml/vial
Propofol Emulsion Injection Segment by Application
Hospital
Clinics
Recovery Center
Propofol Emulsion Injection Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Propofol Emulsion Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Propofol Emulsion Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Propofol Emulsion Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Propofol Emulsion Injection manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Sales, revenue of Propofol Emulsion Injection in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.
Chapter 13: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- 20ml/vial
- 50ml/vial
- 100ml/vial
Applications
- Hospital
- Clinics
- Recovery Center
Companies covered
- Xian Libang Pharmaceutical
- Teva
- Sandoz
- Jiangsu Nhwa Group
- Pfizer
- Sinopharm Guorui Pharm
- Guangdong Jiabo Pharmaceutical
- Fresenius Kabi
- Baxter
- AstraZeneca
- Sagent
- Dr. Reddy's
- B Braun
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.2.1 Global Propofol Emulsion Injection Market Size Estimates and Forecasts (2021-2032)
- 1.2.2 Global Propofol Emulsion Injection Sales Estimates and Forecasts (2021-2032)
- 1.3 Propofol Emulsion Injection Market by Type
- 1.3.1 20ml/vial
- 1.3.2 50ml/vial
- 1.3.3 100ml/vial
- 1.4 Global Propofol Emulsion Injection Market Size by Type
- 1.4.1 Global Propofol Emulsion Injection Market Size Overview by Type (2021-2032)
- 1.4.2 Global Propofol Emulsion Injection Historic Market Size Review by Type (2021-2026)
- 1.4.3 Global Propofol Emulsion Injection Forecasted Market Size by Type (2027-2032)
- 1.5 Key Regions Market Size by Type
- 1.5.1 North America Propofol Emulsion Injection Sales Breakdown by Type (2021-2026)
- 1.5.2 Europe Propofol Emulsion Injection Sales Breakdown by Type (2021-2026)
- 1.5.3 Asia-Pacific Propofol Emulsion Injection Sales Breakdown by Type (2021-2026)
- 1.5.4 South America Propofol Emulsion Injection Sales Breakdown by Type (2021-2026)
- 1.5.5 Middle East and Africa Propofol Emulsion Injection Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
- 2.1 Propofol Emulsion Injection Industry Trends
- 2.2 Propofol Emulsion Injection Industry Drivers
- 2.3 Propofol Emulsion Injection Industry Opportunities and Challenges
- 2.4 Propofol Emulsion Injection Industry Restraints
3 Market Competitive Landscape by Company
- 3.1 Global Top Players by Propofol Emulsion Injection Revenue (2021-2026)
- 3.2 Global Top Players by Propofol Emulsion Injection Sales (2021-2026)
- 3.3 Global Top Players by Propofol Emulsion Injection Price (2021-2026)
- 3.4 Global Propofol Emulsion Injection Industry Company Ranking, 2024 VS 2025 VS 2026
- 3.5 Global Propofol Emulsion Injection Major Company Production Sites & Headquarters
- 3.6 Global Propofol Emulsion Injection Company, Product Type & Application
- 3.7 Global Propofol Emulsion Injection Company Establishment Date
- 3.8 Market Competitive Analysis
- 3.8.1 Global Propofol Emulsion Injection Market CR5 and HHI
- 3.8.2 Global Top 5 and 10 Propofol Emulsion Injection Players Market Share by Revenue in 2025
- 3.8.3 2025 Propofol Emulsion Injection Tier 1, Tier 2, and Tier 3
4 Propofol Emulsion Injection Regional Status and Outlook
- 4.1 Global Propofol Emulsion Injection Market Size and CAGR by Region: 2021 VS 2025 VS 2032
- 4.2 Global Propofol Emulsion Injection Historic Market Size by Region
- 4.2.1 Global Propofol Emulsion Injection Sales in Volume by Region (2021-2026)
- 4.2.2 Global Propofol Emulsion Injection Sales in Value by Region (2021-2026)
- 4.2.3 Global Propofol Emulsion Injection Sales (Volume & Value), Price and Gross Margin (2021-2026)
- 4.3 Global Propofol Emulsion Injection Forecasted Market Size by Region
- 4.3.1 Global Propofol Emulsion Injection Sales in Volume by Region (2027-2032)
- 4.3.2 Global Propofol Emulsion Injection Sales in Value by Region (2027-2032)
- 4.3.3 Global Propofol Emulsion Injection Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Propofol Emulsion Injection by Application
- 5.1 Propofol Emulsion Injection Market by Application
- 5.1.1 Hospital
- 5.1.2 Clinics
- 5.1.3 Recovery Center
- 5.2 Global Propofol Emulsion Injection Market Size by Application
- 5.2.1 Global Propofol Emulsion Injection Market Size Overview by Application (2021-2032)
- 5.2.2 Global Propofol Emulsion Injection Historic Market Size Review by Application (2021-2026)
- 5.2.3 Global Propofol Emulsion Injection Forecasted Market Size by Application (2027-2032)
- 5.3 Key Regions Market Size by Application
- 5.3.1 North America Propofol Emulsion Injection Sales Breakdown by Application (2021-2026)
- 5.3.2 Europe Propofol Emulsion Injection Sales Breakdown by Application (2021-2026)
- 5.3.3 Asia-Pacific Propofol Emulsion Injection Sales Breakdown by Application (2021-2026)
- 5.3.4 South America Propofol Emulsion Injection Sales Breakdown by Application (2021-2026)
- 5.3.5 Middle East and Africa Propofol Emulsion Injection Sales Breakdown by Application (2021-2026)
6 Company Profiles
- 6.1 Xian Libang Pharmaceutical
- 6.1.1 Xian Libang Pharmaceutical Company Information
- 6.1.2 Xian Libang Pharmaceutical Business Overview
- 6.1.3 Xian Libang Pharmaceutical Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.1.4 Xian Libang Pharmaceutical Propofol Emulsion Injection Product Portfolio
- 6.1.5 Xian Libang Pharmaceutical Recent Developments
- 6.2 Teva
- 6.2.1 Teva Company Information
- 6.2.2 Teva Business Overview
- 6.2.3 Teva Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.2.4 Teva Propofol Emulsion Injection Product Portfolio
- 6.2.5 Teva Recent Developments
- 6.3 Sandoz
- 6.3.1 Sandoz Company Information
- 6.3.2 Sandoz Business Overview
- 6.3.3 Sandoz Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.3.4 Sandoz Propofol Emulsion Injection Product Portfolio
- 6.3.5 Sandoz Recent Developments
- 6.4 Jiangsu Nhwa Group
- 6.4.1 Jiangsu Nhwa Group Company Information
- 6.4.2 Jiangsu Nhwa Group Business Overview
- 6.4.3 Jiangsu Nhwa Group Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.4.4 Jiangsu Nhwa Group Propofol Emulsion Injection Product Portfolio
- 6.4.5 Jiangsu Nhwa Group Recent Developments
- 6.5 Pfizer
- 6.5.1 Pfizer Company Information
- 6.5.2 Pfizer Business Overview
- 6.5.3 Pfizer Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.5.4 Pfizer Propofol Emulsion Injection Product Portfolio
- 6.5.5 Pfizer Recent Developments
- 6.6 Sinopharm Guorui Pharm
- 6.6.1 Sinopharm Guorui Pharm Company Information
- 6.6.2 Sinopharm Guorui Pharm Business Overview
- 6.6.3 Sinopharm Guorui Pharm Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.6.4 Sinopharm Guorui Pharm Propofol Emulsion Injection Product Portfolio
- 6.6.5 Sinopharm Guorui Pharm Recent Developments
- 6.7 Guangdong Jiabo Pharmaceutical
- 6.7.1 Guangdong Jiabo Pharmaceutical Company Information
- 6.7.2 Guangdong Jiabo Pharmaceutical Business Overview
- 6.7.3 Guangdong Jiabo Pharmaceutical Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.7.4 Guangdong Jiabo Pharmaceutical Propofol Emulsion Injection Product Portfolio
- 6.7.5 Guangdong Jiabo Pharmaceutical Recent Developments
- 6.8 Fresenius Kabi
- 6.8.1 Fresenius Kabi Company Information
- 6.8.2 Fresenius Kabi Business Overview
- 6.8.3 Fresenius Kabi Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.8.4 Fresenius Kabi Propofol Emulsion Injection Product Portfolio
- 6.8.5 Fresenius Kabi Recent Developments
- 6.9 Baxter
- 6.9.1 Baxter Company Information
- 6.9.2 Baxter Business Overview
- 6.9.3 Baxter Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.9.4 Baxter Propofol Emulsion Injection Product Portfolio
- 6.9.5 Baxter Recent Developments
- 6.10 AstraZeneca
- 6.10.1 AstraZeneca Company Information
- 6.10.2 AstraZeneca Business Overview
- 6.10.3 AstraZeneca Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.10.4 AstraZeneca Propofol Emulsion Injection Product Portfolio
- 6.10.5 AstraZeneca Recent Developments
- 6.11 Sagent
- 6.11.1 Sagent Company Information
- 6.11.2 Sagent Business Overview
- 6.11.3 Sagent Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.11.4 Sagent Propofol Emulsion Injection Product Portfolio
- 6.11.5 Sagent Recent Developments
- 6.12 Dr. Reddy's
- 6.12.1 Dr. Reddy's Company Information
- 6.12.2 Dr. Reddy's Business Overview
- 6.12.3 Dr. Reddy's Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.12.4 Dr. Reddy's Propofol Emulsion Injection Product Portfolio
- 6.12.5 Dr. Reddy's Recent Developments
- 6.13 B Braun
- 6.13.1 B Braun Company Information
- 6.13.2 B Braun Business Overview
- 6.13.3 B Braun Propofol Emulsion Injection Sales, Revenue and Gross Margin (2021-2026)
- 6.13.4 B Braun Propofol Emulsion Injection Product Portfolio
- 6.13.5 B Braun Recent Developments
7 North America by Country
- 7.1 North America Propofol Emulsion Injection Sales by Country
- 7.1.1 North America Propofol Emulsion Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.1.2 North America Propofol Emulsion Injection Sales by Country (2021-2026)
- 7.1.3 North America Propofol Emulsion Injection Sales Forecast by Country (2027-2032)
- 7.2 North America Propofol Emulsion Injection Market Size by Country
- 7.2.1 North America Propofol Emulsion Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2.2 North America Propofol Emulsion Injection Market Size by Country (2021-2026)
- 7.2.3 North America Propofol Emulsion Injection Market Size Forecast by Country (2027-2032)
8 Europe by Country
- 8.1 Europe Propofol Emulsion Injection Sales by Country
- 8.1.1 Europe Propofol Emulsion Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.1.2 Europe Propofol Emulsion Injection Sales by Country (2021-2026)
- 8.1.3 Europe Propofol Emulsion Injection Sales Forecast by Country (2027-2032)
- 8.2 Europe Propofol Emulsion Injection Market Size by Country
- 8.2.1 Europe Propofol Emulsion Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2.2 Europe Propofol Emulsion Injection Market Size by Country (2021-2026)
- 8.2.3 Europe Propofol Emulsion Injection Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
- 9.1 Asia-Pacific Propofol Emulsion Injection Sales by Country
- 9.1.1 Asia-Pacific Propofol Emulsion Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.1.2 Asia-Pacific Propofol Emulsion Injection Sales by Country (2021-2026)
- 9.1.3 Asia-Pacific Propofol Emulsion Injection Sales Forecast by Country (2027-2032)
- 9.2 Asia-Pacific Propofol Emulsion Injection Market Size by Country
- 9.2.1 Asia-Pacific Propofol Emulsion Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2.2 Asia-Pacific Propofol Emulsion Injection Market Size by Country (2021-2026)
- 9.2.3 Asia-Pacific Propofol Emulsion Injection Market Size Forecast by Country (2027-2032)
10 South America by Country
- 10.1 South America Propofol Emulsion Injection Sales by Country
- 10.1.1 South America Propofol Emulsion Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.1.2 South America Propofol Emulsion Injection Sales by Country (2021-2026)
- 10.1.3 South America Propofol Emulsion Injection Sales Forecast by Country (2027-2032)
- 10.2 South America Propofol Emulsion Injection Market Size by Country
- 10.2.1 South America Propofol Emulsion Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2.2 South America Propofol Emulsion Injection Market Size by Country (2021-2026)
- 10.2.3 South America Propofol Emulsion Injection Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
- 11.1 Middle East and Africa Propofol Emulsion Injection Sales by Country
- 11.1.1 Middle East and Africa Propofol Emulsion Injection Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.1.2 Middle East and Africa Propofol Emulsion Injection Sales by Country (2021-2026)
- 11.1.3 Middle East and Africa Propofol Emulsion Injection Sales Forecast by Country (2027-2032)
- 11.2 Middle East and Africa Propofol Emulsion Injection Market Size by Country
- 11.2.1 Middle East and Africa Propofol Emulsion Injection Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2.2 Middle East and Africa Propofol Emulsion Injection Market Size by Country (2021-2026)
- 11.2.3 Middle East and Africa Propofol Emulsion Injection Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
- 12.1 Propofol Emulsion Injection Value Chain Analysis
- 12.1.1 Propofol Emulsion Injection Key Raw Materials
- 12.1.2 Key Raw Materials Price
- 12.1.3 Raw Materials Key Suppliers
- 12.1.4 Manufacturing Cost Structure
- 12.1.5 Propofol Emulsion Injection Production Mode & Process
- 12.2 Propofol Emulsion Injection Sales Channels Analysis
- 12.2.1 Direct Comparison with Distribution Share
- 12.2.2 Propofol Emulsion Injection Distributors
- 12.2.3 Propofol Emulsion Injection Customers
13 Concluding Insights
14 Appendix
- 14.1 Reasons for Doing This Study
- 14.2 Research Methodology
- 14.3 Research Process
- 14.4 Authors List of This Report
- 14.5 Data Source
- 14.5.1 Secondary Sources
- 14.5.2 Primary Sources
- 14.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst